BSEOthers3d ago · 24 Jul 2026, 09:33 pm
Board meeting outcome for the meeting held on July 24, 2026 .
Integrated Proteins Ltd · 519606
✦ AI SummaryMgmt Change
The Board of Directors of Integrated Proteins Ltd has re-designated Mr. Hiren Dhirajlal Shah as the Chairman and Managing Director of the company, subject to approval from shareholders. The company has also fixed the date for an Extra-Ordinary General Meeting (EGM) to be held on August 20, 2026, through video conferencing.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Integrated Proteins Ltd - 519606 - Board Meeting Outcome for Board Meeting Outcome Held On July 24 ,2026 .
Attachments (1)
📄pdf
Download →
79fe7608-311e-49c6-9484-225e48fbe609.pdf
View document text
INTEGRATED PROTEINS LIMITED
Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India
Phone:9428817400
Email ID: integrated.pl2024@gmail.com
Website: www.integratedproteins.com
CIN: L62013GJ1992PLC018426
Date: 24.07.2026
Department of Corporate Services
BSE Limited
25th Floor, Phiroze Jeejeebhoy Towers,
Dalal Street, Fort,
Mumbai – 400001
Scrip Code: 519606
Sub.: Outcome of Board Meeting held on July 24, 2026 under Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements), Regulations, 2015
Dear Sir/ Madam,
Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at its
meeting held today i.e. Friday, July 24, 2026 at the Registered Office of the Company situated at Office no. 218,
Manek Centre, Pandit Nehru Marg, Patel colony, Jamnagar-361008, which commenced at 20:30 HRS(IST) and
concluded at 21:00 HRS (IST) has inter alia considered and approved the following:
1. Re-Designation of Mr. Hiren Dhirajlal Shah (DIN: 09842161), from Additional Executive Director to
the Chairman and Managing Director of the Company.-
Board of Directors accorded their consent to Re-designate Mr. Hiren Shah (DIN: 09842161), the
Additional Executive Director of the Company as " Chairman and Managing Director" of the Company
subject to the approval of members in general meeting of the company, to hold such office for a period
of 5 (Five) commencing from July 24 ,2026 and ending on July 23, 2031 pursuant to provisions of
Sections 196, 197 and 203 read with Schedule V of the Companies Act, 2013 ("the Act") read with the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 and other applicable
provisions, if any, of the Companies Act, 2013 (including any statutory modification or re-enactment
thereof, for the time being in force) and subject to the Memorandum and Articles of Association of the
company.
Further, Mr. Hiren Shah is not debarred from holding the office of Director by virtue of any order of the
Securities and Exchange Board of India (SEBI) or any other such authority.
The particulars required as per SEBI Master Circular No HO/49/14/14(7)2025-CFDPOD2/I/3762/2026
dated January 30, 2026, on Disclosure of material events / information by listed entities under
Regulations 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 are enclosed as Annexure A.
INTEGRATED PROTEINS LIMITED
Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India
Phone:9428817400
Email ID: integrated.pl2024@gmail.com
Website: www.integratedproteins.com
CIN: L62013GJ1992PLC018426
2. Notice of Extra- Ordinary General Meeting-
The Board of Directors has fixed the day, date, time and place for the Extra Ordinary General Meeting
(“EGM”) of the Company. The Board approved convening of an Extra-Ordinary General Meeting (EOGM)
of the Company for the financial year 2026-27 of the members of the Company on Thursday, 20th August
, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM), and approved the Notice
of the EGM along with the Explanatory Statement pursuant to Section 102 of the Companies Act, 2013.
The Board has appointed Mrs. Ankita Tejas Shah, Practicing Company Secretary(Membership No:
A43289, COP No: 16359 ) as a Scrutinizer of the Company for conducting the e-voting process in Extra-
Ordinary General Meeting of the Company.
The e-voting period commences on Monday, 17th August, 2026 at 9.00 A.M. and ends on Wednesday ,
19th August, 2026 at 05.00 P.M.
During this period members of the Company holding shares either in Physical form or in dematerialized
form as of Thursday, August 13 ,2026 (cut-off date for E-voting) may cast their vote through remote e-
voting.
Yours Faithfully,
For , Integrated Proteins Limited
Shivangi Paliwal
Company Secretary
M. No: A80556
INTEGRATED PROTEINS LIMITED
Manek Centre,Of(cid:976)ice No 218,P N Marg,Jamnagar – 361008, Gujarat,India
Phone:9428817400
Email ID: integrated.pl2024@gmail.com
Website: www.integratedproteins.com
CIN: L62013GJ1992PLC018426
Annexure – A
Details as required in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026.
S. No. Particulars Details
1. Name Hiren Dhirajlal Shah
2. Designation Chairman and Managing director
3. Din 09842161
4. Reason for change viz. appointment, Re-Designation of Mr. Hiren Shah(DIN:
resignation, removal, death or otherwise 09842161), the Additional Executive Director, as
the Chairman and Managing Director of the
Company.
5. Date of appointment / cessation (as 24.07.2026(subject to the approval of
applicable) shareholders)
6. Brief profile (in case of appointment) Mr. Hiren holds a Bachelor of Computer
Applications (BCA) degree and a Bachelor of
Laws (LL.B.) degree from Saurashtra University.
He possesses substantial experience in the areas
of finance, accounting, business administration
and corporate management. Over the years, he
has been actively involved in financial planning,
accounting and regulatory compliance matters
and has acquired valuable expertise in financial
management and strategic decision-making.
7. Disclosure of relationship between None
directors (in case of appointment of a
director )